104 related articles for article (PubMed ID: 15497751)
1. Comparative in vitro performance evaluation of the Novopulmon 200 Novolizer and Budesonid-ratiopharm Jethaler: two novel budesonide dry powder inhalers.
de Boer AH; Gjaltema D; Hagedoorn P; Frijlink HW
Pharmazie; 2004 Sep; 59(9):692-9. PubMed ID: 15497751
[TBL] [Abstract][Full Text] [Related]
2. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
[TBL] [Abstract][Full Text] [Related]
3. Variability of fine particle dose and lung deposition of budesonide delivered through two multidose dry powder inhalers.
Munzel U; Marschall K; Fyrnys B; Wedel M
Curr Med Res Opin; 2005 Jun; 21(6):827-33. PubMed ID: 15969882
[TBL] [Abstract][Full Text] [Related]
4. Air classifier technology (ACT) in dry powder inhalation Part 3. Design and development of an air classifier family for the Novolizer multi-dose dry powder inhaler.
de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):72-80. PubMed ID: 16442248
[TBL] [Abstract][Full Text] [Related]
5. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
Zeng XM; MacRitchie HB; Marriott C; Martin GP
Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
[TBL] [Abstract][Full Text] [Related]
6. Stability and performance characteristics of a budesonide powder for inhalation with a novel dry powder inhaler device.
Fyrnys B; Stang N; Wolf-Heuss E
Curr Opin Pulm Med; 2001 Apr; 7 Suppl 1():S7-11. PubMed ID: 11385814
[TBL] [Abstract][Full Text] [Related]
7. Do all dry powder inhalers show the same pharmaceutical performance?
Taylor A; Gustafsson P
Int J Clin Pract Suppl; 2005 Dec; (149):7-12. PubMed ID: 16279997
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic equivalence of the Sofotec Novolizer to established standard devices in COPD and asthma.
Kunkel G; Chuchalin AG
Curr Opin Pulm Med; 2001 Apr; 7 Suppl 1():S15-7. PubMed ID: 11385811
[TBL] [Abstract][Full Text] [Related]
9. The match between adhesive mixture powder formulations for inhalation and the inhaler device.
Thalberg K; Ahmadi R; Stuckel J; Elfman P; Svensson M
Eur J Pharm Sci; 2023 Jul; 186():106457. PubMed ID: 37116546
[TBL] [Abstract][Full Text] [Related]
10. In vitro aerosol performance and dose uniformity between the Foradile Aerolizer and the Oxis Turbuhaler.
Chew NY; Chan HK
J Aerosol Med; 2001; 14(4):495-501. PubMed ID: 11791690
[TBL] [Abstract][Full Text] [Related]
11. Delivery of salbutamol and of budesonide from a novel multi-dose inhaler Airmax.
Zeng XM; O'Leary D; Phelan M; Jones S; Colledge J
Respir Med; 2002 Jun; 96(6):404-11. PubMed ID: 12117039
[TBL] [Abstract][Full Text] [Related]
12. Novolizer: how does it fit into inhalation therapy?
Magnussen H
Curr Med Res Opin; 2005; 21 Suppl 4():S39-46; discussion S47. PubMed ID: 16138944
[TBL] [Abstract][Full Text] [Related]
13. Sustained mechanical and clinical functionality of the flexhaler dry powder inhaler.
Lööf T; Elfman P; Ström P; Törngren A; Borgström L
J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):381-8. PubMed ID: 18823260
[TBL] [Abstract][Full Text] [Related]
14. Gamma scintigraphic evaluation of a novel budesonide dry powder inhaler using a validated radiolabeling technique.
Warren S; Taylor G; Smith J; Buck H; Parry-Billings M
J Aerosol Med; 2002; 15(1):15-25. PubMed ID: 12006142
[TBL] [Abstract][Full Text] [Related]
15. Novolizer: the new technology for the management of asthma therapy.
Köhler D
Curr Opin Pulm Med; 2003 Apr; 9 Suppl 1():S11-6. PubMed ID: 12974537
[TBL] [Abstract][Full Text] [Related]
16. Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder doses.
de Boer AH; Hagedoorn P; Westerman EM; Le Brun PP; Heijerman HG; Frijlink HW
Eur J Pharm Sci; 2006 Jun; 28(3):171-8. PubMed ID: 16650739
[TBL] [Abstract][Full Text] [Related]
17. [A new breath actuated dry powder inhaler (Auto-Jethaler)].
Steiss JO; Heckmann M; Jödicke B; Landmann E; Schüler D; Weber K; Pabst J; Lindemann H
Klin Padiatr; 2007; 219(2):66-9. PubMed ID: 16878285
[TBL] [Abstract][Full Text] [Related]
18. A dry powder inhaler with reduced mouth-throat deposition.
Wang ZL; Grgic B; Finlay WH
J Aerosol Med; 2006; 19(2):168-74. PubMed ID: 16796541
[TBL] [Abstract][Full Text] [Related]
19. Effect of milling and sieving on functionality of dry powder inhalation products.
Steckel H; Markefka P; teWierik H; Kammelar R
Int J Pharm; 2006 Feb; 309(1-2):51-9. PubMed ID: 16377105
[TBL] [Abstract][Full Text] [Related]
20. Influence of the polydispersity of the added fine lactose on the dispersion of salmeterol xinafoate from mixtures for inhalation.
Handoko A; Ian L; Peter SJ
Eur J Pharm Sci; 2009 Feb; 36(2-3):265-74. PubMed ID: 18996188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
